Global Passive Transdermal Drug Delivery Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Passive Transdermal Drug Delivery Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC8207551
  • Published Date :
    May 31, 2024
  • Number of Pages :
    300

Product Description

The Passive Transdermal Drug Delivery market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.

Considering the influence of COVID-19 on the global Passive Transdermal Drug Delivery market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Passive Transdermal Drug Delivery Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Passive Transdermal Drug Delivery market are:
Actavis, Inc.
Bayer AG
Corium International, Inc.
Novartis AG
3M
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Transdermal Corp.
Noven Pharmaceuticals, Inc.
Echo Therapeutics, Inc.
Mylan N.V.

Most important types of Passive Transdermal Drug Delivery products covered in this report are:
Microfluidics
Smart Pill Technology (SPT)

Most widely used downstream fields of Passive Transdermal Drug Delivery market covered in this report are:
Clinic
Hospital
Others

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Passive Transdermal Drug Delivery Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Passive Transdermal Drug Delivery
1.3 Passive Transdermal Drug Delivery Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate from 2019-2031
1.4 Market Segmentation
1.4.1 Types of Passive Transdermal Drug Delivery
1.4.2 Applications of Passive Transdermal Drug Delivery
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Passive Transdermal Drug Delivery Industry Trends
1.5.2 Passive Transdermal Drug Delivery Drivers
1.5.3 Passive Transdermal Drug Delivery Market Challenges
1.5.4 Passive Transdermal Drug Delivery Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Passive Transdermal Drug Delivery Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Passive Transdermal Drug Delivery Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Passive Transdermal Drug Delivery Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Passive Transdermal Drug Delivery
2.2.1 Major Players Manufacturing Base of Passive Transdermal Drug Delivery in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Passive Transdermal Drug Delivery Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Passive Transdermal Drug Delivery
2.3.3 Labor Cost of Passive Transdermal Drug Delivery
2.4 Market Channel Analysis of Passive Transdermal Drug Delivery
2.5 Major Down Stream Customers by Application

3 Global Passive Transdermal Drug Delivery Market, by Type
3.1 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2019-2023)
3.2 Global Passive Transdermal Drug Delivery Production and Market Share by Type (2019-2023)
3.3 Global Passive Transdermal Drug Delivery Revenue and Growth Rate by Type (2019-2023)
3.3.1 Global Passive Transdermal Drug Delivery Revenue and Growth Rate of Microfluidics
3.3.2 Global Passive Transdermal Drug Delivery Revenue and Growth Rate of Smart Pill Technology (SPT)
3.4 Global Passive Transdermal Drug Delivery Price Analysis by Type (2019-2023)
3.4.1 Explanation of Different Type Product Price Trends

4 Passive Transdermal Drug Delivery Market, by Application
4.1 Downstream Market Overview
4.2 Global Passive Transdermal Drug Delivery Consumption and Market Share by Application (2019-2023)
4.3 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Application (2019-2023)
4.3.1 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Clinic (2019-2023)
4.3.2 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Hospital (2019-2023)
4.3.3 Global Passive Transdermal Drug Delivery Consumption and Growth Rate of Others (2019-2023)

5 Global Passive Transdermal Drug Delivery Consumption, Revenue ($) by Region (2019-2023)
5.1 Global Passive Transdermal Drug Delivery Revenue and Market Share by Region (2019-2023)
5.2 Global Passive Transdermal Drug Delivery Consumption and Market Share by Region (2019-2023)
5.3 Global Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4 North America Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4.1 North America Passive Transdermal Drug Delivery Market Under COVID-19
5.4.2 North America Passive Transdermal Drug Delivery SWOT Analysis
5.5 Europe Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.5.1 Europe Passive Transdermal Drug Delivery Market Under COVID-19
5.5.2 Europe Passive Transdermal Drug Delivery SWOT Analysis
5.6 China Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.6.1 China Passive Transdermal Drug Delivery Market Under COVID-19
5.6.2 China Passive Transdermal Drug Delivery SWOT Analysis
5.7 Japan Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.7.1 Japan Passive Transdermal Drug Delivery Market Under COVID-19
5.7.2 Japan Passive Transdermal Drug Delivery SWOT Analysis
5.8 Middle East and Africa Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.8.1 Middle East and Africa Passive Transdermal Drug Delivery Market Under COVID-19
5.8.2 Middle East and Africa Passive Transdermal Drug Delivery SWOT Analysis
5.9 India Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.9.1 India Passive Transdermal Drug Delivery Market Under COVID-19
5.9.2 India Passive Transdermal Drug Delivery SWOT Analysis
5.10 South America Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.10.1 South America Passive Transdermal Drug Delivery Market Under COVID-19
5.10.2 South America Passive Transdermal Drug Delivery SWOT Analysis
5.11 South Korea Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.11.1 South Korea Passive Transdermal Drug Delivery Market Under COVID-19
5.11.2 South Korea Passive Transdermal Drug Delivery SWOT Analysis
5.12 Southeast Asia Passive Transdermal Drug Delivery Consumption, Revenue, Price and Gross Margin (2019-2023)
5.12.1 Southeast Asia Passive Transdermal Drug Delivery Market Under COVID-19
5.12.2 Southeast Asia Passive Transdermal Drug Delivery SWOT Analysis

6 Global Passive Transdermal Drug Delivery Production by Top Regions (2019-2023)
6.1 Global Passive Transdermal Drug Delivery Production by Top Regions (2019-2023)
6.2 North America Passive Transdermal Drug Delivery Production and Growth Rate
6.3 Europe Passive Transdermal Drug Delivery Production and Growth Rate
6.4 China Passive Transdermal Drug Delivery Production and Growth Rate
6.5 Japan Passive Transdermal Drug Delivery Production and Growth Rate
6.6 India Passive Transdermal Drug Delivery Production and Growth Rate

7 Global Passive Transdermal Drug Delivery Consumption by Regions (2019-2023)
7.1 Global Passive Transdermal Drug Delivery Consumption by Regions (2019-2023)
7.2 North America Passive Transdermal Drug Delivery Consumption and Growth Rate
7.3 Europe Passive Transdermal Drug Delivery Consumption and Growth Rate
7.4 China Passive Transdermal Drug Delivery Consumption and Growth Rate
7.5 Japan Passive Transdermal Drug Delivery Consumption and Growth Rate
7.6 Middle East & Africa Passive Transdermal Drug Delivery Consumption and Growth Rate
7.7 India Passive Transdermal Drug Delivery Consumption and Growth Rate
7.8 South America Passive Transdermal Drug Delivery Consumption and Growth Rate
7.9 South Korea Passive Transdermal Drug Delivery Consumption and Growth Rate
7.10 Southeast Asia Passive Transdermal Drug Delivery Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Actavis, Inc. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.2.3 Actavis, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Bayer AG Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.3.3 Bayer AG Sales, Revenue, Price, Gross Margin 2019-2023
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Corium International, Inc. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.4.3 Corium International, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Novartis AG Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.5.3 Novartis AG Sales, Revenue, Price, Gross Margin 2019-2023
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 3M Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.6.3 3M Sales, Revenue, Price, Gross Margin 2019-2023
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 GlaxoSmithKline plc Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.7.3 GlaxoSmithKline plc Sales, Revenue, Price, Gross Margin 2019-2023
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Boehringer Ingelheim GmbH Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.8.3 Boehringer Ingelheim GmbH Sales, Revenue, Price, Gross Margin 2019-2023
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.9.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Sales, Revenue, Price, Gross Margin 2019-2023
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Transdermal Corp. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.10.3 Transdermal Corp. Sales, Revenue, Price, Gross Margin 2019-2023
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Noven Pharmaceuticals, Inc. Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.11.3 Noven Pharmaceuticals, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Echo Therapeutics, Inc. Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.12.3 Echo Therapeutics, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Mylan N.V. Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Passive Transdermal Drug Delivery Product Profiles, Application and Specification
8.13.3 Mylan N.V. Sales, Revenue, Price, Gross Margin 2019-2023
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Passive Transdermal Drug Delivery Market Analysis and Forecast by Type and Application
9.1 Global Passive Transdermal Drug Delivery Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Microfluidics Market Revenue and Volume Forecast (2021-2026)
9.1.2 Smart Pill Technology (SPT) Market Revenue and Volume Forecast (2021-2026)
9.2 Global Passive Transdermal Drug Delivery Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Clinic Market Revenue and Volume Forecast (2021-2026)
9.2.2 Hospital Market Revenue and Volume Forecast (2021-2026)
9.2.3 Others Market Revenue and Volume Forecast (2021-2026)

10 Passive Transdermal Drug Delivery Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Passive Transdermal Drug Delivery Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
 

Search results for Semiconductor and Electronics Industry